Mark E. Delaney
Known title: SVP & Chief Commercial OfficerCIK: 0001955265
Associated companies
Transaction History
| DGX | ▼ Sell | Open Market | 1,600 | $376K | 7/28/2026 | View on chart |
| DGX | ▼ Sell | Other | 34 | $7K | 7/22/2026 | View on chart |
| DGX | ▼ Sell | Other | 37 | $7K | 4/20/2026 | View on chart |
| DGX | ▲ Buy | Grant | 5,682 | $1.2M | 3/4/2026 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 2,326 | $477K | 3/4/2026 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 188 | $39K | 3/2/2026 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 205 | $43K | 2/18/2026 | View on chart |
| DGX | ▲ Buy | Grant | 1,586 | $0 | 2/18/2026 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 230 | $48K | 2/18/2026 | View on chart |
| DGX | ▼ Sell | Other | 15 | $3K | 1/28/2026 | View on chart |
| DGX | ▲ Buy | Option Exercise | 7,846 | $1.1M | 11/18/2025 | View on chart |
| DGX | ▲ Buy | Option Exercise | 100 | $14K | 11/18/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 7,946 | $1.5M | 11/18/2025 | View on chart |
| DGX | ▲ Buy | Grant | 15 | $3K | 10/21/2025 | View on chart |
| DGX | ▼ Sell | Other | 17 | $3K | 7/21/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 874 | $153K | 5/13/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 874 | $154K | 5/12/2025 | View on chart |
| DGX | ▼ Sell | Other | 25 | $4K | 4/21/2025 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 256 | $43K | 3/26/2025 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 1,823 | $317K | 3/4/2025 | View on chart |
| DGX | ▲ Buy | Grant | 5,317 | $924K | 3/4/2025 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 214 | $37K | 2/26/2025 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 242 | $41K | 2/19/2025 | View on chart |
| DGX | ▲ Buy | Grant | 1,815 | $0 | 2/12/2025 | View on chart |
| DGX | ▼ Sell | Open Market | 403 | $66K | 2/5/2025 | View on chart |
| DGX | ▼ Sell | Other | 4 | $632 | 1/29/2025 | View on chart |
| DGX | ▼ Sell | Other | 4 | $598 | 10/21/2024 | View on chart |
| DGX | ▼ Sell | Open Market | 420 | $60K | 7/24/2024 | View on chart |
| DGX | ▼ Sell | Other | 6 | $882 | 7/22/2024 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 170 | $22K | 3/26/2024 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 225 | $28K | 2/28/2024 | View on chart |
| DGX | ▲ Buy | Grant | 2,348 | $0 | 2/14/2024 | View on chart |
| DGX | ▼ Sell | Tax Withholding | 170 | $23K | 3/24/2023 | View on chart |
| DGX | ▲ Buy | Grant | 1,919 | $0 | 2/23/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Quest Diagnostics Preps for Q3 Earnings Amid Dividend Focus
Quest Diagnostics is approaching its third-quarter earnings report, with recent coverage highlighting its position as a dividend-paying stock. The company maintains a 2.10% dividend yield and trades at a 24.7 P/E ratio. Analysts currently set an average price target of $251.40, which sits above the current trading range.
Quest Diagnostics Preps for Q3 Earnings Amid Dividend Focus. Quest Diagnostics is approaching its third-quarter earnings report, with recent coverage highlighting its position as a dividend-paying stock. The company maintains a 2.10% dividend yield and trades at a 24.7 P/E ratio. Analysts currently set an average price target of $251.40, which sits above the current trading range.